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Abstract 
Hendra virus (HeV) and Nipah virus (NiV) are emerging zoonotic viruses that cause severe and often lethal respiratory illness and 
encephalitis in humans. Henipaviruses can infect a wide range of species and human-to-human transmission has been observed for NiV. 
While the exact route of transmission in humans is not known, experimental infection in different animal species suggests that infection can 
be efficiently initiated after respiratory challenge. The limited data on histopathological changes in fatal human cases of HeV and NiV 
suggest that endothelial cells are an important target during the terminal stage of infection; however, it is unknown where these viruses 
initially establish infection and how the virus disseminates from the respiratory tract to the central nervous system and other organs. Here we 
review the current concepts in henipavirus pathogenesis in humans. 
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Introduction 
Hendra virus (HeV) and Nipah virus (NiV) are two 
members of the genus Henipavirus (HNV; family 
Paramyxoviridae) that cause acute and severe 
respiratory illness and encephalitis in humans. HeV 
was identified in 1994 as the causative agent of an 
acute respiratory disease and febrile illness in horses 
and humans, respectively [1]. To date there have been 
only seven human infections with HeV, of which four 
were fatal (57%) [2]. Several outbreaks of NiV have 
been identified in Malaysia, Singapore, Bangladesh 
and India since 1998 [2]. The outbreaks in Malaysia 
and Singapore have primarily been associated with the 
development of severe febrile encephalitis with a case 
fatality rate of 38%, while the more recent outbreaks 
in Bangladesh and India are associated with a higher 
prevalence of respiratory disease as well as a higher 
case fatality rate ranging from 43% to 100% in 
sporadic cases [2]. While the exact route of 
transmission in humans is not known, experimental 
infection in different animal species suggests that 
infection can be efficiently initiated after inhalation of 
virus particles [3-5]. Endothelial cells have been 
identified as an important target of infection [6]; 
however, it is unknown how the virus spreads to the 
central nervous system (CNS). Here we review the 
current knowledge on henipavirus pathogenesis.  
Transmission 
Fruit bats (Pteropodidae family) have been 
identified as the reservoir for HNV [7,8] and their 
geographic distribution extends beyond the outbreak 
sites to West Africa [9]. In addition to the isolation of 
HeV and NiV from these species, recent studies have 
identified evidence of multiple HNV-like viruses, 
including the isolation of Cedar virus in Australia, 
which is not believed to be pathogenic in humans [10]. 
Infected bats primarily shed HNV via the urinary route 
and can infect humans through involvement of 
intermediate amplification hosts such as horses (HeV) 
and pigs (NiV outbreak in Malaysia) [11]. More 
recently, outbreaks of NiV in Bangladesh have been 
associated with consumption of raw date palm sap, 
which is believed to be contaminated with NiV from 
bats urinating in the sap collection jars [12]. Finally, 
several outbreaks of NiV in Bangladesh resulted in 
person-to-person transmission [13]. Transmission is 
believed to be through contact with respiratory 
secretions or aerosols, as the virus can be isolated from 
throat swabs [14].  
 
Respiratory infection 
The respiratory epithelium is an important first line 
of defense and actively involved in inflammation and 
host defense against infectious diseases. In human 
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cases of NiV infection, NiV can be detected in 
bronchiolar epithelial cells and is shed mainly by 
nasopharyngeal and tracheal secretions in the early 
phase of the illness [14]. Patients with symptomatic 
respiratory tract infections were significantly more 
likely to transmit NiV [15]. Histological changes in 
the lungs of NiV cases include necrotizing alveolitis 
with hemorrhage, pulmonary edema, and aspiration 
pneumonia [16]. Multinucleated giant cells are 
occasionally noted in alveolar septum and alveolar 
spaces adjacent to necrotic areas. Intra-alveolar 
inflammatory cells are common. The first fatal human 
case of HeV infection resulted in severe respiratory 
disease in which the lungs had gross lesions of 
congestion hemorrhage and edema associated with 
histological chronic alveolitis [1]. Overall, 
histopathological changes of tracheal/bronchial 
epithelium were uncommon. In experimental animal 
models, viral antigen is initially detectable in the 
bronchi and alveoli, primarily targeting the bronchial 
epithelium and type II pneumocytes [3] (Figure 1A). 
We recently showed that HNV can efficiently 
infect epithelial cells from the lower human 
respiratory tract and replicate to high titers [17]. While 
human-to-human transmission has been observed only 
in outbreaks with NiV-B, these data suggest that both 
NiV and HeV have the potential for human-to-human 
transmission through aerosols. 
HNV infection of the respiratory epithelium results 
in the induction of inflammatory cytokines which 
result in the recruitment of immune cells and can 
progress to an Acute Respiratory Distress Syndrome 
(ARDS)-like disease [3]. Infection of the lower 
respiratory tract epithelium results in a differential 
inflammatory response depending on the sites of 
infection [17]. HNV infection of the small airway 
epithelium resulted in induction of key inflammatory 
mediators such as IL-6, 8, IL-1α, MCP-1, G-CSF, 
GM-CSF and CXCL10. Interestingly, inflammatory 
cytokine expression was significantly lower in 
trachea/bronchial epithelium. This observation is in 
agreement with previous reports that no inflammation 
is observed in the bronchial epithelium of NiV cases. 
Many of these key cytokines in HNV infection play a 
role in ARDS and are also highly expressed during 
infection with other virulent respiratory viruses, such 
as H5N1 and SARS-CoV [18-20]. 
 
Viremia 
During the late stages of disease, virus replication 
spreads from the respiratory epithelium to the 
endothelium in the lungs (Figure 1B) [3,16]. The 
infection can sometimes trigger a prominent vasculitis 
in small vessels and capillaries as characterized by 
endothelial syncytium and mural necrosis [16]. Large 
vessels are usually not affected. HNV can then enter 
the bloodstream and disseminate throughout the host 
in either free form or by binding host leukocytes. In 
addition to the lungs, important target organs are the 
brain, spleen and kidneys, and viremia following 
respiratory infection can lead to multi-organ failure 
[1]. Interestingly, HNV has been shown to bind to 
CD3+ leukocytes without entry or replication of the 
virus [21]. In hamsters, passive transfer of NiV loaded 
leukocytes to naïve animals results in lethal infection 
[21]. In contrast in pigs, HNV can productively infect 
monocytes, CD6+CD8+ T lymphocytes and NK cells 
[22]. CD6 is a ligand for the activated leukocyte cell 
adhesion molecule ALCAM (CD166), which is highly 
expressed on the microvascular endothelial cells of the 
blood-air and the blood-brain barrier [22]. HNV 
infection of T cells expressing CD6 may explain the 
preferential tropism of NiV for small blood vessels of 
the lung and brain. It is currently unknown whether 
binding of HNV or infection of human leukocytes will 
affect the phenotype of the cells, such as increase CD6 
expression, thereby preferentially homing to the CNS.  
Entry into the CNS is thought to occur through two 
distinct pathways: anterogradely via the olfactory 
nerve and/or via the hematogenous route through the 
choroid plexus and cerebral blood vessels [23]. 
Infection of the CNS in humans is characterized by 
vasculitis, thrombosis, parenchymal necrosis, and 
presence of viral inclusion bodies [16]. Plaques with 
necrosis are found in both the gray and white matter 
and vasculitis, thrombosis, and parenchymal edema 
and inflammation are found in the vicinity of these 
plaques. Inflammatory cells found in the CNS 
primarily consist of neutrophils, macrophages, 
lymphocytes, and reactive microglia [16]. HNV 
antigen can typically be detected in neurons and 
neuronal processes and endothelial cells (Figure 1C). 
Occasionally, viral antigen is also detected in 
ependymal cells and rare glial cells in the white matter 
[16]. 
 
 
Entry in the CNS 
HNV infection of the CNS and the development of 
neurological signs are associated with the disruption of 
the blood-brain barrier (BBB) and expression of TNF-
α and IL-1β [3]. These pro-inflammatory cytokines 
have been shown to play a role in increasing the 
permeability of the blood-brain barrier as well as the 
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induction of neuronal injury and death. While the 
source of TNF-α and IL-1β expression in the brain is 
currently unknown, they can be released by microglia, 
which are also infected by HNV. However, whether 
disruption of the BBB is a direct cytopathic effect of 
virus replication in the microvasculature or an indirect 
effect through expression of TNF-α and IL-1β by 
bystander cells such as neurons and microglia remains 
unclear. 
Experimental studies in various animal models 
have shown direct entry of the CNS by HNV, through 
the olfactory nerve [23,24]. In these models, NiV 
infects the olfactory epithelium in the nasal turbinates 
(Figure 1D). NiV subsequently infects neurons 
extending through the cribriform plate into the 
olfactory bulb, providing a direct route entry into the 
CNS. NiV then disseminates to the olfactory tubercle 
and throughout the ventral cortex. It is currently 
unknown whether this route is also biologically 
relevant in human infections, since the olfactory 
epithelial surface is relatively large in these species 
compared to man. 
 
Conclusion 
The molecular mechanisms of HNV pathogenesis 
remain largely unknown. Several animal models are 
available, such as hamsters, ferrets and African green 
monkeys [3-5], which closely mimic the disease 
progression seen in human cases; however, this 
research is hampered by lack of reagents and sufficient 
animal numbers. Biologically relevant in vitro models 
of primary human cell cultures are also available to 
study the different components of HNV infection in 
the respiratory epithelium [17], endothelium and 
neurons [25] and will allow for an in-depth analysis of 
the host-pathogen interactions. These studies have 
already shown differences in host responses depending 
on the cell types and virus strains. The latter is of 
particular interest since strain variations have been 
observed between the NiV outbreaks in Malaysia and 
Bangladesh, correlating with differences in outcome of 
disease. Similarly, the more recent equine cases of 
HeV have been associated with a higher prevalence of 
neurological disease and were associated with strain 
variations. It is hypothesized that these genetic 
changes may result in differences in cell and/or tissue 
tropism. The recent development of reverse genetics 
systems for NiV and HeV will allow direct testing of 
this hypothesis. 
Finally, a better understanding of the molecular 
mechanisms of HNV pathogenesis will be important 
for developing effective counter measures to prevent 
and treat infection with these often lethal viruses. 
 
Figure 1A-D. Cell tropism of Nipah virus in lungs and brain of 
infected ferrets 
Nipah virus nucleoprotein is detected in bronchial epithelium (A) and endothelium (B) in 
the lungs, neurons in the brain (C) and olfactory epithelium (D) in the nasal turbinates of 
ferrets intranasally infected with the Malaysia strain of Nipah virus. 40X magnification. 
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